U.S. Media Stock News

Compass came into this earnings print already on a tear, with the stock up about 47% over the past three months, and the market added another 6.9% on the day. That kind of move only sticks if the quarter backs it up. The headline here is simple. Compass turned in record Q2 revenue of US$4.3b and delivered adjusted earnings that pushed the trailing price tag to a rich 142x P/E. For a brokerage platform long viewed as a high-growth, low-profit story, this report puts profitability and leverage...

AES came into this earnings season wearing a value label, with a P/E of 7.6x and a stock that had drifted slightly over the past week. The immediate reaction tells the story. The stock barely moved, up just 0.1% to US$14.70, even as the company reported solid trailing 12 month earnings and an 11.1% net margin. The real headline is the strain behind that income statement. Interest costs continue to press on the business, and a 4.79% dividend leans on thin free cash flow. The market appears to...

Alaska Air Group stock slipped about 1% to roughly US$52 after earnings, a muted reaction for a carrier that many investors still view as a disciplined operator with upside to repair its profit story. The headline this quarter is not the loss itself; it is the size of the fuel and cost hit needed to push a business with US$4.1b in quarterly revenue into a US$76m net loss. The expectation gap is clear. The long term thesis for Alaska Air Group is about margin rebuild. Today’s numbers underline...

Suja Life just suffered a brutal sentiment reset. The stock closed at US$6.14, down 46% on the day, as investors rushed to reprice a growth story that now looks more complicated than the headline revenue line suggests. The trigger was not a collapse in sales. Net sales for Q2 stood at US$83.9m and adjusted earnings before interest, tax, depreciation and amortisation hit US$14.6m with a 17.5% margin. The shock came from the squeeze between that solid beverage profitability and softer full year...

Hecla Mining’s stock jumped 7.5% to US$16.54 today, yet the real story is not just a bullish tape. The market is reacting to a quarter that put free cash flow and profitability squarely in focus. Hecla generated US$136 million of free cash flow and reported US$118 million of net income from continuing operations, which reinforced a trailing net margin of 28.3%. For a precious metals producer, that margin profile is the headline, and it is now alongside a richer P/E of 24.1x that already...

Arista Networks is often viewed as one of the purest ways to gain exposure to high end cloud and artificial intelligence networking. Despite this, the stock only moved about 3.6% higher to around US$197 after this earnings release. That muted reaction came in a quarter that crossed US$3.0b in revenue for the first time and delivered a net profit margin above 40%. The key point for investors is the strength of Arista Networks’ profitability at this scale. The company is now combining multi...

Limbach Holdings entered this earnings day after a difficult few months, with the stock already down sharply. The market response was far harsher than the headline numbers suggested, and the share price fell about 36% to US$49.50 by the close. The key issue was not revenue, but margins. Gross margin slipped to 21.5% and adjusted EBITDA margin declined to 8.0%, even as revenue reached US$173.5 million. Investors responded to that profit pressure as if the growth mix and acquisition narrative...

In the past week, Tyson Foods reported fiscal third-quarter 2026 results showing flat sales at US$13.87 billion year on year, while net income rose to US$182 million and adjusted earnings per share of US$0.99 came in slightly below analyst expectations. At the same time, Tyson cut its full-year profit outlook as deepening losses in its beef segment, driven by tight U.S. cattle supplies and high cattle costs, outweighed solid performance in chicken and prepared foods. Next, we'll examine how...

Agilent Technologies recently received European regulatory certification for its PD-L1 IHC 22C3 pharmDx test as a companion diagnostic in certain ovarian cancers, supporting identification of patients who may benefit from Merck’s Keytruda therapy. This cancer-specific approval enhances Agilent’s position in immuno-oncology diagnostics and deepens its collaboration with Merck, potentially broadening its clinical testing footprint across Europe. We’ll now explore how this new European ovarian...

The market rushed to reward Paramount Skydance, pushing the stock up about 4.5% to roughly $8.76, yet the real story is about an earnings engine still grinding through a long repair. Q2 2026 net income from ongoing operations stayed slim at about $41 million on revenue of roughly $6.9b, a small profit set against a trailing year that remains in the red. For a stock that has fallen over the past three months, this quarter reads less like a clean turnaround and more like the first credible...

loanDepot stock barely flinched after earnings, slipping just 0.9% to close near US$1, even though the headline story was a sharply smaller quarterly loss. Net loss narrowed to US$4.5m in Q2 on roughly US$295m of revenue, a marked improvement from the heavy red ink investors saw at the start of the year. The short term tape still looks bruised, with the share price down double digits over the past month. Yet the earnings call focused on a longer game, with management emphasizing rising gain...

Mercury General stock added 2.8% today to US$109.61, even though the real story sits in the insurer’s profit engine rather than the headline price pop. The key signal is margin. Trailing net profit margin sits at 13.7% compared with 5.1% a year earlier, and earnings over the past year are reported to be close to triple last year’s level. Investors cheering the move are reacting to a company that, on recent numbers, is earning more on each premium dollar while still trading on a single digit...

Alphatec Holdings just gave shareholders a jolt. The stock closed at US$9.57, down about 7.5% on the day, even though the headline from Q2 was clear. Revenue reached about US$214 million and adjusted earnings before interest, tax, depreciation and amortisation climbed to about US$36 million. Short term traders focused on the red on the screen. Longer term investors will likely be more interested in what this quarter says about Alphatec Holdings’ push toward higher margins, sustained double...

Select Water Solutions stock came into today on a strong run, with double digit gains over the past week and month, only to meet fresh Q2 numbers that put the focus squarely on earnings power. The headline is simple. Profit and revenue both sit solidly in the black, with Q2 net income of US$21.0 million on US$395.8 million of revenue, and basic EPS of roughly US$0.15. The bigger story for long term investors is the valuation strain. Select Water Solutions trades on a P/E that is far above...

Wynn Resorts stock jumped 3.6% to about US$101 in regular trading after its Q2 report, a sharp move for a company whose 90 day return has been under pressure. The market is reacting to one thing above all else: profitability is firming even as revenue holds near US$1.9b and net income from ongoing operations reaches roughly US$140m. That short term pop sits against a longer horizon where earnings have been growing over multiple years but face clear balance sheet risks. The headline today is...

The market marked Celanese down almost 5% today. Yet the headline from this earnings release is not collapse but compression. The stock sold off as investors fixated on the company’s still-weak trailing profit picture, even as quarterly earnings per share climbed back above US$1 and net income returned to a positive US$127m in Q2. For a chemicals producer that has been wrestling with losses and interest burdens, that profit squeeze and the struggle to cover financing costs remain the...

Healthy growth is hard to find when global data is so mixed, with some regions picking up speed and others cooling. A focused screener that looks for companies where analysts expect strong earnings growth over the next 3 years, while also checking that balance sheets are in acceptable shape, can help you cut through the noise. The Healthy high growth potential screener does exactly that. In this article you will see 3 stocks from this universe that stand out on growth quality and financial...

PACS Group stock closed up 1.9% at US$45.64 after its latest report, a measured move for a company that just reported another quarter of stronger earnings. Net income reached US$76.4 million on US$1.43b of revenue, resulting in a trailing net margin of 4.8% that now sits well above last year’s level. The short-term reaction is modest. The bigger story is that investors now have to weigh that improving profitability against a P/E of 26.8x, along with multi-year earnings growth forecasts that...

WeRide (WRD) stock is back in focus after the company announced a partnership with GreenMobility to roll out Level 4 autonomous shared mobility services in Denmark, marking its first entry into the Nordic region. See our latest analysis for WeRide. The GreenMobility agreement comes after a tough period for WeRide shareholders, with the year to date share price return down 36.32% and the 1 year total shareholder return down 31.03%. However, recent 7 day and 30 day share price returns of 3.46%...

Lattice Semiconductor shareholders woke up to a sentiment shock. The stock dropped about 7% to US$128.31 on the first trading day after earnings, even as the company posted record Q2 revenue of US$201.1m and strong earnings per share of US$0.14 on a basic basis and US$0.53 on a non generally accepted accounting principles basis. The market is treating the print as a problem. The numbers read more like a stress test in a stock that was already priced for perfection. Impressed by Lattice...

Interparfums stock gave up 4% today, which looks more like a mood swing than a verdict on the business. The fragrance group just posted Q2 revenue of US$341.0m with basic earnings per share of US$0.95. These numbers sit in the context of a trailing twelve month basic earnings per share figure of US$5.23. The key issue is margin pressure. Operating profitability for the first half of 2026 has softened, even as tariff refunds and strong brands help cushion the impact. That is what today’s price...

Bio-Rad Laboratories stock jumped about 4.5% in regular trading, which indicates that traders responded positively to the latest results. The bigger story is less about a one-day move and more about whether this quarter marks a cleaner earnings run rate after a very choppy year. Q2 revenue was US$651 million and non-GAAP earnings per share were US$2.62, roughly in line with the same period last year. For long-term holders, the key question is how this steadier quarter fits with modest growth...

TransDigm Group’s stock slipped about 1.6% today, yet the quarterly story investors just saw was about profit power holding firm despite a heavy balance sheet. Q3 revenue reached US$2.741b with net income of US$539m, keeping basic earnings per share near double digits at US$9.39. Those profits sit on top of roughly US$33.7b of gross debt and interest coverage of about 3x, which keeps leverage in focus. For a stock that had cooled a bit over the past month, this earnings report highlights how...

Adaptive Biotechnologies stock barely budged after earnings, closing up just 0.2% around US$24.61. That muted move sits awkwardly against a quarter that put its core cancer minimal residual disease diagnostics front and center. Total revenue reached US$71.6m, while the company reported a net loss of US$39.8m that was heavily influenced by debt extinguishment and interest tied to the OrbiMed agreement. The key takeaway for investors is margin and profit pressure alongside a strong MRD growth...